Webinar | Mercia EIS Webinar 2021/22 Exits Showcase

Join Dr. Paul Mattick and Ruth Coleman as they go through the details of Mercia’s EIS recent exits performance. The pair will be discuss Genba Digital, Snappy Shopper, In-Part and BEW to name a few. (Capital at Risk. Past performance is not a reliable indicator of future return) Visit Mercia’s EIS area Register for the

Industry heavyweights join MIP Diagnostics Board

Following the announcement of a follow on investment round of £4.3million, MIP Diagnostics has announced the appointment of two new directors to its Board. Dr Mike Evans, former CEO at Oxford Gene Technology will join as Chair whilst Roche Diagnostics’ former Global Head of Strategy and Business Development, Michele Pedrocchi, joins as Non-Executive Director. Mike

Webinar | Launch of our Knowledge-Intensive Impact EIS

Join Dr. Paul Mattick and Stefan Helm as they walk you through the launch of Mercia’s  Knowledge-Intensive Impact EIS. Reasons to consider investing: To have a positive societal impact To reduce your 2020/2021 taxes The low minimum of £10,000 provides access to a new investors Other important factors to consider: Fund closes on 4th April

Mercia announces further direct investment into MIP Diagnostics

Mercia is pleased to announce completion of a second tranche investment round of £4.3million into existing direct investment portfolio company, MIP Diagnostics Limited, a UK-based nanotechnology business. As part of this round Mercia invested £1.1million from its own balance sheet, alongside existing syndicate investors including the Business Growth Fund, Downing Ventures and Calculus Capital. This

In-person retail shopping is awful. What comes next?

The pain of shopping in-person presents opportunities for entrepreneurs well-versed in retail tech, and for retailers wanting to protect their margins as we move towards the Metaverse, a reason to invest in their online presence. Mercia’s Lee Lindley catalogues his own experience and why retail needs a better UX. They say every cloud has a

Inova acquires IN-PART, matchmaking platform for academia-industry collaboration

Inova announces the acquisition of IN-PART, a digital matchmaking platform dedicated to academia-industry collaboration. Along with the recent acquisition of Labiotech, this move consolidates Inova’s position as a leader and pioneer in the digitalization of the biopharma partnering space, supported by the €60 million investment from global investment firm Carlyle (NASDAQ: CG) and reaffirmation of

North East Venture Fund round-up with Thea Tebble

Investment Associate for the North East Venture Fund, Thea Tebble, returns to give us a round-up of the latest investments in the North-East, focusing on the tech sector. This update features The Handbag Clinic, 3deo, ART Health Solutions and many more. Visit the NEVF area